Orthotech Research & Development Pty Ltd v Maxx Orthopedics, Inc

Link copied
Case Copied 30 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by Orthotech Research & Development Pty Ltd to application under section 92 of the Trade Marks Act 1995 (Cth) by Maxx Orthopedics, Inc for removal of trade mark number 1217830 (Class 10) – FREEDOM PKR, in the name of Orthotech Research & Development Pty Ltd.

Delegate:

Blake Knowles

Representation:

Opponent: Patrick Spelman of RGB Lawyers.  

Applicant: Vincent Powell of AJ Pietras & Co.    

Decision:

2022 ATMO 65

Trade Marks Act 1995 (Cth) – application for removal under s 92(4)(b) – no use during relevant period – circumstances established that were an obstacle to use for some goods – discretion not exercised – trade mark to be partially removed.

Background

  1. Maxx Orthopedics, Inc. (‘Removal Applicant’) on 21 April 2020 filed an application under s 92(4)(b) of the Trade Marks Act 1995 (Cth)0F[1] (‘Removal Application’) for the complete removal of the following registered trade mark (‘Registration’):

    [1] Unless otherwise stated, each reference to a section or regulation in these reasons is a reference to the Trade Marks Act 1995(the ‘Act’) or the Trade Marks Regulations 1995 (Cth) (the ‘Regulations’), respectively.

    Trade Mark Number:  1217830

    Trade Mark:  FREEDOM PKR

    (‘Trade Mark’)

    Class 10: Orthopaedic articles; orthopaedic implants and orthopaedic  implant components; instruments for implantation of orthopaedic implants

    (‘Goods’)

  2. Orthotech Research & Development Pty Ltd (‘Removal Opponent’) is the owner of the Registration. The Removal Opponent filed a notice of intention to oppose the Removal Application on 19 June 2020, followed by a statement of grounds and particulars (‘SGP’) on 18 July 2020. The Removal Applicant filed a notice of intention to defend the opposition to the Removal Application on 1 September 2020.

  3. The parties were given the opportunity to file evidence in accordance with the timetable set out in reg 9.16. The Removal Opponent filed Evidence in Support (‘EIS’) on 8 December 2020. The Removal Applicant did not file Evidence in Answer, and as such, the Removal Opponent did not file Evidence in Reply.

  4. Both parties requested to be heard by videoconference. The matter was heard before me, as a delegate of the Registrar, on 7 March 2022. The Removal Opponent was represented by Mr Patrick Spelman of RBG Lawyers. The Removal Applicant was represented by Mr Vincent Powell of AJ Pietras & Co. I have decided the matter based on the particulars set out in the SGP, the EIS, and the submissions of the parties.  

  5. As the Removal Application was filed on 21 April 2020, for the purposes of deciding the opposition, the relevant three-year is the period ending on 21 March 2020 (‘Relevant Period’).   

    Evidence

  6. The EIS consists of a declaration by Mr Samuel Scott-Young, sole director of the Removal Opponent, made on 8 December 2020 with Exhibits SSY-1 to SSY-11.

  7. Mr Scott-Young declares that the Trade Mark has been predominantly used in respect of unicompartmental knee prosthesis (‘Prosthesis’). Mr Scott-Young explains that the Prosthesis was designed and implanted by some of…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Orthotech Research & Development Pty Ltd v Maxx Orthopedics,... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2022] ATMO 65
Decision Date

CaseChat Overview and Summary

This matter concerned an application by Maxx Orthopedics, Inc. (the "Removal Applicant") to remove from the Register of Trade Marks the trade mark "PKR" registered in the name of Orthotech Research & Development Pty Ltd (the "Removal Opponent"). The Removal Applicant sought removal on the grounds of non-use. The Removal Opponent opposed the removal application, arguing that the trade mark had been used in relation to orthopaedic articles and implants, specifically knee prostheses, during the relevant three-year period ending 21 March 2020.

The primary legal issue before the delegate was whether the Removal Opponent had established genuine use of the trade mark "PKR" in Australia in relation to knee prostheses during the relevant period. This involved considering whether the use by a related entity, Orthotech Pty Ltd, and the licensing arrangements constituted use by the Removal Opponent, and whether the evidence demonstrated actual and substantial use of the trade mark in the course of trade.

The delegate considered evidence that the trade mark had been used in relation to unicompartmental knee prostheses, which were designed and implanted by surgeons and purchased by hospitals. It was asserted that "PKR" was common knowledge amongst the usual customers, referring to "partial knee replacement." The delegate noted that the Removal Opponent had licensed the trade mark to Orthotech Pty Ltd, a related entity, and that Orthotech had sold prostheses bearing the trade mark in Australia until February 2017. The prostheses had also been advertised on Orthotech's website. However, the delegate found that the evidence did not establish use of the trade mark within the relevant period, particularly given the cessation of manufacturing by the original supplier in Italy in 2017.

Ultimately, the delegate declined to exercise discretion in favour of the Removal Opponent and ordered that the trade mark be partially removed from the Register. The specification of goods was to be amended to "Orthopaedic articles and implants being knee prostheses." The partial removal was stayed for one month to allow for potential appeal, and no order for costs was made as both parties had achieved a measure of success.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

As the Removal Application was filed on 21 April 2020, for the purposes of deciding the opposition, the relevant three-year is the period ending on 21 March 2020 (‘Relevant Period’). Evidence The EIS consists of a declaration by Mr Samuel Scott-Young, sole director of the Removal Opponent, made on 8 December 2020 with Exhibits SSY-1 to SSY-11. Mr Scott-Young declares that the Trade Mark has been predominantly used in respect of unicompartmental knee prosthesis (‘Prosthesis’). Mr Scott-Young explains that the Prosthesis was designed and implanted by some of Australia’s word-renowned knee surgeons and was purchased predominantly by orthopaedic surgeons and hospitals across Australia. Mr Scott-Young declares that that the letters PKR in the Trade Mark are a reference to ‘partial knee replacement’ and this is common knowledge amongst usual customers of the Prosthesis. Mr Scott-Young declares that the Removal Opponent licensed the Trade Mark to a related entity, Orthotech Pty Ltd (‘Orthotech’). Mr Scott-Young states that the Removal Opponent is a wholly owned subsidiary of Orthotech, and that he is the sole director of both companies. Mr Scott-Young explains that both companies ‘acted with the same objective of maximising the sales of the Prosthesis and enhance the value of the Prosthesis and its associated Mark’. Mr Scott-Young declares that Orthotech sold the Prosthesis bearing the Trade Mark in Australia regularly from 2011 through to the most recent sale to St Vincents Private Hospital in Sydney on 17 February 2017. Mr Scott-Young declares that the Prosthesis has remained advertised for sale on Orthotech’s website (‘Website’), during the Relevant Period. Mr Scott-Young annexes a copy of an Internet Archive Wayback Machine extract dated 12 August 2017 which displays the following product:(‘Wayback Extract’) Mr Scott-Young declares that between 5 October 2016 and 30 June 2018, the Removal Opponent granted distribution rights in respect of the Prosthesis to PurePlay Orthopaedics Pty Ltd (‘PurePlay’). Mr Scott-Young annexes copies of a sub-distributor agreement and amendment letter. Mr Scott-Young notes that the agreement remains on foot and that it places restrictions on PurePlay altering or modifying the Prosthesis. Mr Scott-Young declares that the Removal Opponent and Orthotech were unable to source an appropriately qualified and licensed manufacturer of the Prosthesis during the Relevant Period. Mr Scott-Young states that after acquiring the Trade Mark and associated rights from Stryker Australia Pty Ltd in 2010, the Removal Opponent engaged an Italian company, Samo S.p.A (‘Samo’) to manufacture the Prosthesis and sell it to the Removal Opponent and Orthotech for distribution in Australia and New Zealand (with the last sale of the Prosthesis occurring in Australia in February 2017). Mr Scott-Young states: ‘Samo experienced financial difficulties and various intellectual property rights in the Prosthesis were sold to BeijingFitoMedicalCo. Ltd (which I understand traded as FitSamo).’…‘Following Samo’s sale of the intellectual property rights in the Prosthesis, Samo S.p.A ceased manufacturing the Prosthesis and neither [the Opponent] nor Orthotech were able to acquire further Products from Samo S.p.A.’

Decision

Reasons for decision

As such, I decline to exercise discretion in favour of the Removal Opponent. Decision The Removal Opponent has established a ground of opposition to removal of the Trade Mark in relation to orthopaedic articles and implants being knee prostheses. As such, the Trade Mark should be partially removed, with removal to be effected by the specification of Goods being amended to:Class 10: Orthopaedic articles and implants being knee prostheses Given it is the right of both parties to appeal this decision to the courts, the partial removal shall not take place until at least one month from today. If the Registrar is served with a notice of appeal before then, the removal shall not occur until the appeal has either been discontinued or otherwise dealt with as the Court sees fit. Both parties sought an award of costs. As both parties have had a measure of success, I decline to award costs. Blake KnowlesHearing OfficerDelegate of the Registrar of Trade Marks29 April 2022

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.